AbbVie (ABBV) Long-Term Debt Repayments (2015 - 2025)

AbbVie (ABBV) has 11 years of Long-Term Debt Repayments data on file, last reported at $8.0 million in Q4 2025.

• Long-Term Debt Repayments for Q4 2025 came in at $8.0 million, down 99.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.8 billion (down 69.92% YoY), and the FY2025 annual result was $6.8 billion, down 29.29% from the prior year.
• Long-Term Debt Repayments eased to $8.0 million in Q4 2025 per ABBV's latest filing, from $9.0 million in the prior quarter.
• Over five years, Long-Term Debt Repayments peaked at $6.9 billion in Q4 2022 and troughed at $2.0 million in Q2 2022.
• A 5-year average of $2.3 billion and a median of $2.2 billion in 2021 frame the typical range for Long-Term Debt Repayments.
• The sharpest annual moves came in 2022 and 2023: Long-Term Debt Repayments sank 99.94% in 2022, then soared 50000.0% in 2023.
• A 5-year view of Long-Term Debt Repayments shows it stood at $3.8 billion in 2021, then jumped by 82.6% to $6.9 billion in 2022, then plunged by 73.81% to $1.8 billion in 2023, then jumped by 221.18% to $5.8 billion in 2024, then tumbled by 99.86% to $8.0 million in 2025.
• Business Quant data shows ABBV's Long-Term Debt Repayments at $8.0 million in Q4 2025, $9.0 million in Q3 2025, and $3.8 billion in Q2 2025.